
  
    
      
        Introduction_NNP
        IL-_NNP 1_CD β_NN is_VBZ a_DT proinflammataory_NN cytokine_NN that_WDT has_VBZ myriad_JJ
        effects_NNS on_IN cells_NNS ,_, increasing_VBG proliferation_NN ,_, activating_VBG
        inflammatory_JJ responses_NNS ,_, and_CC inducing_VBG matrix_NN remodeling_VBG
        through_IN the_DT production_NN of_IN neutral_JJ proteases_NNS ._. Since_IN most_JJS
        cells_NNS can_MD both_DT express_VB and_CC respond_VB to_TO IL-_NNP 1_CD β_NN ,_, complex_JJ
        signaling_VBG programs_NNS are_VBP likely_RB required_VBN to_TO modulate_VBP the_DT
        timing_NN and_CC magnitude_NN of_IN responses_NNS to_TO this_DT cytokine_NN [_NN 1_CD ]_NN ._. It_PRP
        is_VBZ well_RB documented_VBN that_WDT elevated_JJ expression_NN of_IN IL-_NNP 1_CD β_NN in_IN the_DT
        joint_JJ results_NNS in_IN the_DT activation_NN of_IN inflammatory_JJ and_CC
        degradative_JJ programs_NNS in_IN synovial_NN cells_NNS ,_, contributing_VBG to_TO the_DT
        progression_NN of_IN rheumatoid_NN arthritis_NN [_NN 2_CD ]_NN ._. Recent_JJ work_NN by_IN
        Hasty_NNP and_CC coworkers_NNS [_NN 3_CD ]_NN has_VBZ demonstrated_VBN that_IN local_JJ
        expression_NN of_IN IL-_NNP 1_CD β_NN by_IN articular_NN chondrocytes_NNS activates_NNS
        autocrine_NN gene_NN expression_NN ,_, which_WDT contributes_VBZ to_TO the_DT
        pathogenesis_NNS of_IN osteoarthritis_NNS (_( OA_NNP )_) ._. Furthermore_RB ,_,
        IL-_NNP 1_CD -_: receptor_NN antagonists_NNS are_VBP effective_JJ inhibitors_NNS of_IN
        inflammation_NN and_CC connective_JJ tissue_NN destruction_NN in_IN animal_NN
        models_NNS of_IN arthritis_NN [_NN 2_CD ,_, 4_CD ,_, 5_CD ]_NN ._. Together_RB ,_, these_DT studies_NNS
        implicate_VB IL-_NNP 1_CD β_NN as_IN a_DT central_JJ mediator_NN of_IN pathogenesis_NNS in_IN
        arthritis_NN ._.
        Activation_NNP of_IN this_DT pathologic_JJ process_NN is_VBZ complex_JJ ,_, most_RBS
        likely_JJ involving_VBG the_DT activation_NN or_CC repression_NN of_IN numerous_JJ
        signal_NN /_NN transduction_NN pathways_NNS ,_, with_IN subsequent_JJ effects_NNS on_IN
        many_JJ genes_NNS ._. Our_PRP$ previous_JJ work_NN has_VBZ focused_VBN on_IN the_DT pathways_NNS
        by_IN which_WDT IL-_NNP 1_CD β_NN induces_VBZ several_JJ members_NNS of_IN the_DT family_NN of_IN
        matrix_NN metalloproteinases_NNS (_( MMPs_NNP )_) ,_, enzymes_NNS that_WDT are_VBP active_JJ
        at_IN neutral_JJ pH_NN and_CC that_IN collectively_RB degrade_NN the_DT various_JJ
        components_NNS of_IN the_DT extracellular_NN matrix_NN ._. Specifically_RB ,_, we_PRP
        have_VBP focused_VBN on_IN MMP-_NNP 1_CD and_CC MMP-_NNP 13_CD ,_, interstitial_NN collagenases_NNS
        that_WDT have_VBP the_DT unique_JJ ability_NN to_TO initiate_VB cleavage_NN of_IN the_DT
        triple_JJ helix_NN comprising_VBG the_DT stromal_NN collagens_NNS types_NNS I_PRP ,_, II_NNP ,_,
        and_CC III_NNP ._. Elevated_NNP expression_NN of_IN MMP-_NNP 1_CD and_CC MMP-_NNP 13_CD by_IN stromal_NN
        cells_NNS and_CC chondrocytes_NNS in_IN response_NN to_TO IL-_NNP 1_CD β_NN contributes_VBZ to_TO
        the_DT pathogenesis_NNS of_IN connective_JJ tissue_NN disorders_NNS [_NN 6_CD ,_, 7_CD ,_, 8_CD ,_,
        9_CD ,_, 10_CD ,_, 11_CD ]_NN ._. Studies_NNS from_IN this_DT laboratory_NN and_CC others_NNS showed_VBD
        that_IN IL-_NNP 1_CD activates_NNS MMP-_NNP 1_CD and_CC MMP-_NNP 13_CD gene_NN expression_NN
        through_IN common_JJ signaling_VBG pathways_NNS [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ]_NN ._.
        Specifically_RB ,_, nuclear_JJ translocation_NN of_IN NF-κB_NNP and_CC
        mitogen-activated_JJ protein_NN kinase_NN (_( MAPK_NNP )_) stimulation_NN of_IN
        activator_NN protein-_NN 1_CD (_( AP-_NNP 1_LS )_) are_VBP required_VBN for_IN transcription_NN
        of_IN cytokine-induced_JJ MMP-_NNP 1_CD and_CC MMP-_NNP 13_CD ._. Furthermore_RB ,_,
        cycloheximide_NN blocks_NNS mRNA_NN expression_NN of_IN both_DT collagenases_NNS [_NN
        11_CD ,_, 16_CD ]_NN ,_, indicating_VBG that_DT expression_NN of_IN immediate_JJ early_JJ
        genes_NNS is_VBZ required_VBN for_IN MMP-_NNP 1_CD and_CC MMP-_NNP 13_CD gene_NN expression_NN ._.
        Thus_RB ,_, IL-_NNP 1_CD β_NN activation_NN of_IN collagenase_NN gene_NN expression_NN
        requires_VBZ the_DT increased_VBN expression_NN of_IN a_DT panel_NN of_IN essential_JJ
        transcription_NN factors_NNS and_CC signaling_VBG intermediates_NNS ,_, as_RB well_RB
        as_IN the_DT initiation_NN of_IN signaling_VBG cascades_NNS that_WDT activate_VBP these_DT
        factors_NNS ._.
        IL-_NNP 1_CD also_RB contributes_VBZ to_TO the_DT pathogenesis_NNS of_IN arthritis_NN
        by_IN increasing_VBG the_DT proliferation_NN of_IN mesenchymal_NN cells_NNS and_CC by_IN
        enhancing_VBG the_DT expression_NN of_IN other_JJ inflammatory_JJ mediators_NNS [_NN
        17_CD ,_, 18_CD ,_, 19_CD ]_NN ._. This_DT complex_JJ alteration_NN in_IN cellular_JJ phenotype_NN
        probably_RB involves_VBZ the_DT coordinated_VBN increase_NN and_CC decrease_NN of_IN
        genes_NNS for_IN cytokines_NNS and_CC growth_NN factors_NNS ,_, adhesion_NN molecules_NNS ,_,
        and_CC signaling_VBG intermediates_NNS ._. The_DT recent_JJ availability_NN of_IN
        microarray_NN technology_NN has_VBZ made_VBN it_PRP possible_JJ to_TO perform_VB an_DT
        extensive_JJ analysis_NN of_IN IL-_NNP 1_CD modulation_NN of_IN genes_NNS in_IN cells_NNS
        that_WDT are_VBP central_JJ players_NNS in_IN arthritic_JJ disease_NN ._.
        We_PRP therefore_RB carried_VBD out_RP a_DT microarray_NN analysis_NN of_IN
        IL-_NNP 1_CD β-stimulated_JJ chondrocytic_JJ cells_NNS in_IN order_NN to_TO identify_VB
        immediate_JJ early_JJ genes_NNS that_WDT could_MD contribute_VB to_TO phenotypic_JJ
        changes_NNS relevant_JJ to_TO OA_NNP ._. In_IN these_DT studies_NNS ,_, we_PRP used_VBD the_DT human_JJ
        chondrosarcoma_NN cell_NN line_NN SW_NNP 1353_CD ,_, for_IN three_CD important_JJ
        reasons_NNS ._. First_LS ,_, we_PRP ,_, and_CC others_NNS ,_, have_VBP found_VBN that_IN when_WRB
        treated_VBN with_IN IL-_NNP 1_CD β_NN ,_, SW_NNP 1353_CD cells_NNS serve_VBP as_IN an_DT appropriate_JJ
        model_NN for_IN primary_JJ chondrocytes_NNS in_IN OA_NNP [_NN 11_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ]_NN ._.
        Second_JJ ,_, the_DT amount_NN of_IN total_JJ RNA_NNP required_VBD for_IN microarray_NN
        analysis_NN precludes_VBZ the_DT use_NN of_IN primary_JJ human_JJ chondrocytes_NNS
        for_IN these_DT studies_NNS ._. Third_NNP ,_, the_DT inherent_JJ genetic_JJ variation_NN in_IN
        primary_JJ human_JJ chondrocyte_NN cultures_NNS could_MD bias_NN the_DT gene_NN
        expression_NN profile_NN and_CC lead_VB to_TO erroneous_JJ conclusions_NNS ._. We_PRP
        found_VBD increased_VBN expression_NN of_IN a_DT large_JJ cohort_NN of_IN
        transcription_NN factors_NNS ,_, cytokines_NNS ,_, growth_NN factors_NNS ,_, and_CC
        signaling_VBG intermediate_JJ genes_NNS that_WDT are_VBP potential_JJ regulators_NNS
        of_IN metalloproteinase_NN gene_NN expression_NN ,_, proliferation_NN ,_, and_CC
        sustained_VBD inflammation_NN ._. Alternatively_RB ,_, this_DT was_VBD accompanied_VBN
        by_IN a_DT decrease_NN in_IN a_DT modest_JJ number_NN of_IN genes_NNS also_RB belonging_VBG to_TO
        these_DT categories_NNS ,_, suggesting_VBG that_IN IL-_NNP 1_CD β_NN substantially_RB
        reprograms_NNS gene_NN expression_NN in_IN chondrocytes_NNS ._. A_DT subset_NN of_IN
        these_DT IL-_NNP 1_CD β-stimulated_JJ genes_NNS was_VBD then_RB confirmed_VBN by_IN
        semiquantitative_JJ reverse_NN transcriptase_NN polymerase_NN chain_NN
        reaction_NN (_( RT-PCR_NNP )_) ._. This_DT characterization_NN of_IN IL-_NNP 1_CD β-induced_JJ
        immediate_JJ early_JJ genes_NNS in_IN chondrocytic_JJ cells_NNS identifies_VBZ
        candidate_NN mediators_NNS of_IN the_DT expression_NN of_IN colla-genase_JJ genes_NNS
        in_IN arthritis_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Cell_NNP culture_NN
          SW_NNP 1353_CD chondrosarcoma_NN cells_NNS were_VBD grown_VBN to_TO confluence_NN
          in_IN Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS medium_NN supplemented_JJ with_IN
          10_CD %_NN fetal_JJ bovine_JJ serum_NN (_( Hyclone_NNP ,_, Logan_NNP ,_, UT_NNP ,_, USA_NNP )_) ,_,
          penicillin_NN /_NN streptomycin_NN ,_, and_CC L-_NNP glutamine_NN (_( Cellgro_NNP ,_,
          Mediatech_NNP ,_, Herndon_NNP ,_, VA_NNP ,_, USA_NNP )_) ._. At_IN the_DT beginning_NN of_IN each_DT
          experiment_NN ,_, cells_NNS were_VBD washed_VBN three_CD times_NNS with_IN Hank_NNP 's_POS
          buffered_JJ sterile_JJ saline_NN (_( Cellgro_NNP )_) to_TO remove_VB traces_NNS of_IN
          serum_NN and_CC were_VBD placed_VBN in_IN Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS
          medium_NN containing_VBG 0_CD ._. 2_CD %_NN lactalbumin_NN hydrolysate_NN
          (_( Gibco_NNP /_NN BRL_NNP ,_, Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_) ._. Then_RB cells_NNS were_VBD either_CC
          left_VBD unstimu-lated_JJ or_CC treated_VBN with_IN 10_CD ng_NN /_NN ml_NN recombinant_JJ
          IL-_NNP 1_CD β_NN (_( Promega_NNP ,_, Madison_NNP ,_, WI_NNP ,_, USA_NNP )_) ._. This_DT concentration_NN of_IN
          IL-_NNP 1_CD was_VBD found_VBN to_TO be_VB optimal_NN for_IN activation_NN of_IN MMP-_NNP 13_CD
          gene_NN expression_NN in_IN these_DT cells_NNS (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Harvest_NNP and_CC microarray_NN analysis_NN of_IN mRNA_NN
          For_IN microarray_NN analysis_NN ,_, two_CD confluent_NN 150_CD -_: mm_NN plates_NNS
          of_IN SW_NNP 1353_CD cells_NNS were_VBD cultured_JJ in_IN lactalbumin_NN hydrolysate_NN ,_,
          or_CC lactalbumin_NN hydrolysate_NN plus_CC 10_CD ng_NN /_NN ml_NN IL-_NNP 1_CD β_NN ,_, for_IN 2_CD
          hours_NNS ._. Cells_NNP were_VBD then_RB washed_VBN with_IN Hank_NNP 's_POS buffered_JJ
          sterile_JJ saline_NN solution_NN and_CC homogenized_JJ in_IN 2_CD ml_NN Triazol_NNP
          Reagent_NNP (_( Gibco_NNP /_NN BRL_NNP )_) ,_, and_CC RNA_NNP was_VBD purified_JJ in_IN accordance_NN
          with_IN the_DT manufacturer_NN 's_POS instructions_NNS ._. The_DT RNA_NNP pellets_NNS
          were_VBD stored_VBN in_IN 70_CD %_NN ethanol_NN and_CC shipped_VBN on_IN dry_JJ ice_NN to_TO
          Clontech_NNP Laboratories_NNPS (_( Palo_NNP Alto_NNP ,_, CA_NNP ,_, USA_NNP )_) via_IN express_VB
          courier_NN ._. Clontech_NNP analyzed_VBD the_DT RNA_NNP using_VBG their_PRP$ Atlas_NNP
          Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP array_NN (_( 1176_CD unique_JJ genes_NNS )_) and_CC
          AtlasImage_NNP 1_CD ._. 0_CD software_NN ._. We_PRP chose_VBD this_DT data_NNS baseline_NN
          because_IN it_PRP represents_VBZ a_DT large_JJ number_NN of_IN genes_NNS that_WDT may_MD be_VB
          expressed_VBN during_IN development_NN and_CC again_RB during_IN disease_NN
          pathology_NN ._. We_PRP further_RBR classified_VBN genes_NNS that_WDT increased_VBD or_CC
          decreased_VBN by_IN twofold_NN or_CC more_JJR ,_, and_CC sorted_VBN them_PRP using_VBG
          Microsoft_NNP Excel_NNP ._.
        
        
          Reverse_VBP transcriptase_NN polymerase_NN chain_NN
          reaction_NN
          A_DT subset_NN of_IN genes_NNS whose_WP$ expression_NN was_VBD increased_VBN by_IN
          IL-_NNP 1_CD β_NN was_VBD then_RB confirmed_VBN using_VBG a_DT radioactive_JJ RT-PCR_NNP
          assay_NN ._. Briefly_NNP ,_, RNA_NNP was_VBD treated_VBN with_IN DNAse_NNP I_PRP and_CC then_RB 2_CD
          μg_NN was_VBD reverse_VB transcribed_JJ with_IN Moloney_NNP murine_NN leukemia_NN
          virus_NN reverse_NN transcriptase_NN and_CC oligodT_NN primers_NNS ._. One_CD
          tenth_NN of_IN the_DT reverse_JJ transcriptase_NN reaction_NN was_VBD amplified_VBN
          using_VBG gene-specific_JJ primers_NNS ,_, Platinum_NN Taq_NNP DNA_NNP polymerase_NN
          and_CC 33_CD PdATP_NNP ._. Single-band_NNP products_NNS were_VBD resolved_VBN on_IN native_JJ
          acrylamide_NN gels_NNS and_CC visualized_JJ by_IN autoradiography_NN ._. Table_NNP
          1_CD shows_VBZ the_DT gene-specific_JJ primers_NNS that_WDT were_VBD used_VBN ._.
        
      
      
        Results_NNS and_CC discussion_NN
        Table_NNP 2_CD shows_VBZ the_DT results_NNS of_IN an_DT analysis_NN using_VBG Clontech_NNP 's_POS
        Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP Array_NNP and_CC total_JJ RNA_NNP from_IN SW_NNP 1353_CD cells_NNS
        treated_VBN with_IN IL-_NNP 1_CD β_NN (_( 10_CD ng_NN /_NN ml_NN )_) for_IN 2_CD hours_NNS ._. This_DT analysis_NN
        revealed_VBD substantial_JJ increases_NNS or_CC decreases_NNS in_IN the_DT
        expression_NN of_IN several_JJ known_VBN IL-_NNP 1_CD β-responsive_JJ genes_NNS ._. These_DT
        include_VBP transcription_NN factors_NNS (_( panel_NN A_DT )_) ,_, cytokines_NNS ,_, growth_NN
        factors_NNS ,_, and_CC their_PRP$ receptors_NNS (_( panel_NN B_NNP )_) ,_, proteases_NNS ,_, matrix_NN
        proteins_NNS ,_, and_CC adhesion_NN molecules_NNS (_( panel_NN C_NNP )_) ,_, as_RB well_RB as_IN
        signaling_VBG intermediates_NNS and_CC tumor_NN suppressors_NNS (_( panel_NN
        D_NNP )_) ._.
        We_PRP focused_VBD on_IN genes_NNS for_IN transcription_NN factors_NNS because_IN
        they_PRP have_VBP been_VBN reported_VBN as_IN IL-_NNP 1_CD -_: responsive_JJ immediate_JJ early_JJ
        genes_NNS in_IN chondrocytes_NNS [_NN 23_CD ]_NN ._. Members_NNS of_IN the_DT NF-κB_NNP ,_, AP-_NNP 1_CD ,_,
        and_CC ets_NNS families_NNS of_IN transcription_NN factors_NNS substantially_RB
        increased_VBN in_IN the_DT Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP array_NN (_( see_VB Table_NNP 2_CD ,_,
        panel_NN A_DT )_) ._. To_TO confirm_VB the_DT effect_NN of_IN IL-_NNP 1_CD β_NN on_IN AP-_NNP 1_CD family_NN
        members_NNS ,_, we_PRP assayed_JJ Jun_NNP family_NN members_NNS by_IN RT-PCR_NNP (_( Fig_NNP ._. 1_LS )_) ._.
        We_PRP found_VBD that_IN the_DT c-_NN Jun_NNP and_CC JunB_NNP genes_NNS increased_VBN
        transiently_RB within_IN 1_CD hour_NN of_IN IL-_NNP 1_CD treatment_NN ,_, before_IN the_DT
        induction_NN of_IN the_DT MMP-_NNP 13_CD gene_NN ._. The_DT expression_NN profiles_NNS for_IN
        c-_NN Jun_NNP and_CC JunB_NNP were_VBD similar_JJ to_TO the_DT profile_NN for_IN egr-_NN 1_CD ,_,
        another_DT immediate_JJ early_JJ gene_NN in_IN IL-_NNP 1_CD -_: stimulated_VBN
        chondrocytes_NNS [_NN 23_CD ]_NN ._. In_IN contrast_NN ,_, the_DT JunD_NNP gene_NN was_VBD
        constitutively_RB expressed_VBN ,_, and_CC IL-_NNP 1_CD β_NN increased_VBD this_DT
        expression_NN modestly_RB ._. These_DT data_NNS show_VBP that_IN in_IN
        IL-_NNP 1_CD β-stimulated_JJ chondrocytes_NNS ,_, all_DT three_CD Jun_NNP family_NN members_NNS
        are_VBP expressed_VBN and_CC can_MD contribute_VB to_TO MMP_NNP gene_NN expression_NN ._.
        Furthermore_RB ,_, RT-PCR_NNP analysis_NN of_IN the_DT JunB_NNP gene_NN (_( Fig_NNP ._. 1_LS )_)
        validated_JJ the_DT gene_NN expression_NN profile_NN derived_VBN from_IN the_DT
        Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP array_NN (_( Table_NNP 2_CD ,_, panel_NN A_DT )_) ._.
        Transcription_NNP factor_NN genes_NNS that_WDT were_VBD modulated_JJ by_IN IL-_NNP 1_CD β_NN
        included_VBD members_NNS from_IN the_DT NF-κB_NNP family_NN (_( relB_NN ,_, p_NN 100_CD /_NN p_NN 52_CD ,_,
        p_NN 105_CD /_NN p_NN 50_CD ,_, IκB-ε_NNP ,_, c-rel_JJ ,_, and_CC p_NN 65_CD )_) ,_, the_DT AP-_NNP 1_CD family_NN (_( fra-_NN 1_CD
        and_CC junB_NN )_) ,_, and_CC the_DT ETS_NNP family_NN (_( ets-_NN 1_LS )_) ._. While_IN it_PRP is_VBZ well_RB
        established_VBN that_IN NF-κB_NNP proteins_NNS translocate_NN to_TO the_DT nucleus_NN
        upon_IN IL-_NNP 1_CD stimulation_NN [_NN 24_CD ]_NN ,_, we_PRP were_VBD surprised_VBN to_TO find_VB so_RB
        many_JJ family_NN members_NNS expressed_VBD simultaneously_RB ._. This_DT suggests_VBZ
        that_IN in_IN IL-_NNP 1_CD -_: stimulated_VBN chondrocytes_NNS ,_, NF-κB_NNP family_NN members_NNS
        may_MD compete_VB for_IN dimerization_NN partners_NNS and_CC for_IN binding_JJ sites_NNS
        in_IN responsive_JJ genes_NNS ._.
        Members_NNS of_IN the_DT AP-_NNP 1_CD family_NN of_IN transcription_NN factors_NNS are_VBP
        essential_JJ transcriptional_NN activators_NNS for_IN both_DT the_DT MMP-_NNP 1_CD and_CC
        MMP-_NNP 13_CD genes_NNS [_NN 25_CD ,_, 26_CD ,_, 27_CD ]_NN ,_, and_CC these_DT transcription_NN factors_NNS
        are_VBP activated_VBN by_IN extracellular_NN stimuli_NNS through_IN MAPK_NNP
        pathways_NNS [_NN 28_CD ]_NN ._. JunB_NNP was_VBD identified_VBN as_IN an_DT IL-_NNP 1_CD -_: inducible_JJ
        gene_NN in_IN chondrocytes_NNS by_IN the_DT Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP array_NN (_( Table_NNP
        1_LS )_) and_CC this_DT finding_VBG was_VBD confirmed_VBN by_IN RT-PCR_NNP (_( Fig_NNP ._. 1_LS )_) ._.
        Levels_NNP of_IN JunB_NNP mRNA_NN peaked_VBD within_IN 1_CD hour_NN of_IN IL-_NNP 1_CD
        stimulation_NN and_CC began_VBD to_TO decline_VB after_IN 2_CD hours_NNS ._. This_DT was_VBD
        somewhat_RB surprising_JJ ,_, since_IN MAPK_NNP pathways_NNS do_VBP not_RB activate_VBP
        JunB_NNP [_NN 29_CD ]_NN and_CC in_IN some_DT systems_NNS JunB_NNP antagonizes_NNS
        transcriptional_NN activation_NN by_IN c-_NN Jun_NNP [_NN 30_CD ]_NN ._. Since_IN c-_NN Jun_NNP ,_,
        JunB_NNP ,_, and_CC JunD_NNP are_VBP all_DT expressed_VBN in_IN IL-_NNP 1_CD -_: treated_VBN SW_NNP 1353_CD
        chondrocytic_JJ cells_NNS ,_, it_PRP is_VBZ not_RB clear_JJ which_WDT family_NN member_NN is_VBZ
        responsible_JJ for_IN transcriptional_NN activation_NN of_IN collagenase_NN
        genes_NNS ._. Perhaps_RB the_DT functional_JJ transcriptional_NN complex_NN is_VBZ
        determined_VBN by_IN induced_VBN expression_NN and_CC activation_NN of_IN AP-_NNP 1_CD
        accessory_JJ proteins_NNS ,_, such_JJ as_IN the_DT Fos_NNP family_NN member_NN Fra-_NNP 1_CD ,_, or_CC
        the_DT ets_NNS family_NN member_NN ets-_NN 1_CD [_NN 31_CD ]_NN ._. This_DT cohort_NN of_IN AP-_NNP 1_CD ,_,
        Fos_NNP ,_, and_CC ets_NNS family_NN members_NNS may_MD also_RB preferentially_RB bind_NN to_TO
        different_JJ AP-_NNP 1_CD sites_NNS in_IN MMP_NNP promoters_NNS ,_, with_IN subtle_JJ effects_NNS
        on_IN gene_NN expression_NN [_NN 32_CD ]_NN ._.
        egr-_NN 1_CD is_VBZ an_DT IL-_NNP 1_CD -_: inducible_JJ immediate_JJ early_JJ gene_NN in_IN
        chondrocytes_NNS [_NN 23_CD ]_NN and_CC has_VBZ been_VBN implicated_VBN in_IN the_DT elevated_VBD
        MMP-_NNP 1_CD gene_NN expression_NN observed_VBD in_IN rheumatoid_NN synoviocytes_NNS [_NN
        33_CD ,_, 34_CD ]_NN ._. Surprisingly_RB ,_, egr-_NN 1_CD expression_NN was_VBD increased_VBN only_RB
        1_CD ._. 3_CD -_: fold_VB in_IN this_DT Human_NNP Cancer_NNP 1_CD ._. 2_CD K_NNP array_NN (_( data_NNS not_RB shown_VBN )_) ._.
        However_RB ,_, when_WRB this_DT gene_NN was_VBD analyzed_VBN by_IN RT-PCR_NNP ,_, we_PRP found_VBD a_DT
        robust_JJ increase_NN in_IN egr-_NN 1_CD mRNA_NN within_IN 1_CD hour_NN of_IN IL-_NNP 1_CD
        stimulation_NN ,_, which_WDT declined_VBD significantly_RB by_IN 2_CD hours_NNS (_( Fig_NNP ._.
        1_LS )_) ._. Thus_RB ,_, the_DT relatively_RB short_JJ half-life_NN of_IN egr-_NN 1_CD mRNA_NN
        resulted_VBD in_IN an_DT underestimation_NN of_IN IL-_NNP 1_CD induction_NN of_IN this_DT
        gene_NN in_IN the_DT microarray_NN ._. It_PRP is_VBZ therefore_RB probable_JJ that_IN an_DT
        array_NN using_VBG RNA_NNP from_IN cells_NNS treated_VBN for_IN 1_CD hour_NN with_IN IL-_NNP 1_CD
        would_MD identify_VB additional_JJ important_JJ genes_NNS ._.
        IL-_NNP 1_CD β_NN repressed_JJ three_CD transcription_NN factor_NN genes_NNS ,_,
        including_VBG HOX-_NNP 4_CD A_DT ,_, the_DT retinoblastoma-like_JJ protein_NN 2_CD ,_, and_CC
        mothers_NNS against_IN dpp_NN homologue_NN 4_CD (_( SMAD_NNP 4_LS )_) ._. SMAD_NNP 4_CD contributes_VBZ
        to_TO transforming_VBG growth_NN factor-β_JJ (_( TGF-β_NNP )_) -_: dependent_JJ
        transcription_NN of_IN the_DT alpha_NN 2_CD (_( I_NN )_) -_: collagen_NN (_( COL_NNP 1_CD A_DT 2_LS )_) [_NN 35_CD ]_NN and_CC
        aggrecan_NN [_NN 36_CD ]_NN genes_NNS ._. Furthermore_RB ,_, our_PRP$ microarray_NN data_NNS
        demonstrated_VBN that_IN IL-_NNP 1_CD inhibited_VBD Col_NNP 2_CD A_DT 1_CD expression_NN by_IN
        1_CD ._. 6_CD -_: fold_VB in_IN SW_NNP 1353_CD cells_NNS (_( data_NNS not_RB shown_VBN )_) ._. It_PRP has_VBZ been_VBN
        reported_VBN that_IN IL-_NNP 1_CD inhibition_NN of_IN Col_NNP 2_CD A_DT 1_CD gene_NN expression_NN
        requires_VBZ the_DT p_NN 38_CD MAPK_NNP pathway_NN [_NN 37_CD ]_NN ._. Perhaps_RB inhibition_NN of_IN
        SMAD_NNP 4_CD synthesis_NN is_VBZ another_DT component_NN of_IN IL-_NNP 1_CD -_: dependent_JJ
        Col_NNP 2_CD A_DT 1_CD gene_NN repression_NN ._. While_IN IL-_NNP 1_CD promotes_VBZ cartilage_NN
        degradation_NN through_IN MMP_NNP synthesis_NN and_CC inhibits_NNS matrix_NN
        deposition_NN by_IN reducing_VBG Col_NNP 2_CD A_DT 1_CD gene_NN expression_NN ,_, TGF-β_NNP has_VBZ
        the_DT opposite_JJ effect_NN on_IN chondrocytes_NNS [_NN 3_CD ]_NN ._. Thus_RB ,_, it_PRP is_VBZ
        tempting_JJ to_TO speculate_VB that_IN IL-_NNP 1_CD antagonizes_NNS the_DT effects_NNS of_IN
        TGF-β_NNP by_IN blocking_VBG expression_NN of_IN essential_JJ signaling_VBG
        intermediates_NNS ,_, such_JJ as_IN SMAD_NNP 4_CD ._.
        Cytokines_NNP and_CC growth_NN factors_NNS and_CC their_PRP$ receptors_NNS were_VBD a_DT
        major_JJ group_NN of_IN IL-_NNP 1_CD -_: modulated_JJ genes_NNS in_IN chondrocytes_NNS (_( Table_NNP
        2_CD ,_, panel_NN B_NNP )_) ._. For_IN instance_NN ,_, leukemia_NN inhibitor_NN factor_NN
        precursor_NN (_( LIF_NNP )_) was_VBD substantially_RB induced_VBN by_IN IL-_NNP 1_CD β_NN in_IN
        SW_NNP 1353_CD cells_NNS ,_, and_CC this_DT is_VBZ consistent_JJ with_IN previous_JJ reports_NNS
        of_IN LIF_NNP as_IN an_DT IL-_NNP 1_CD -_: responsive_JJ gene_NN in_IN chondrocytes_NNS [_NN 38_CD ,_,
        39_CD ]_NN ._. Recently_RB ,_, LIF_NNP was_VBD reported_VBN to_TO induce_VB MMP-_NNP 13_CD gene_NN
        expression_NN [_NN 40_CD ]_NN ,_, and_CC this_DT may_MD contribute_VB to_TO the_DT role_NN of_IN
        this_DT cytokine_NN in_IN arthritis_NN pathology_NN [_NN 38_CD ]_NN ._. IL-_NNP 6_CD expression_NN
        was_VBD increased_VBN in_IN IL-_NNP 1_CD -_: treated_VBN cells_NNS ,_, and_CC while_IN this_DT may_MD
        affect_VB a_DT variety_NN of_IN cellular_JJ functions_NNS in_IN chondrocytes_NNS ,_,
        this_DT cytokine_NN does_VBZ not_RB seem_VB to_TO be_VB required_VBN for_IN IL-_NNP 1_CD -_: induced_VBN
        suppression_NN of_IN proteoglycan_NN synthesis_NN in_IN cartilage_NN [_NN 41_CD ]_NN ._.
        Interestingly_RB ,_, there_EX was_VBD a_DT concurrent_JJ increase_NN in_IN
        expression_NN of_IN platelet-derived_JJ growth_NN factor_NN (_( PDGF_NNP )_)
        subunits_NNS ,_, and_CC a_DT decrease_NN in_IN PDGF_NNP receptor_NN subunits_NNS ._. Perhaps_RB
        this_DT is_VBZ a_DT mechanism_NN of_IN ensuring_VBG paracrine_NN ,_, but_CC not_RB
        autocrine_NN ,_, effects_NNS of_IN PDGF_NNP in_IN cytokine-stimulated_JJ
        chondrocytes_NNS ._. The_DT role_NN of_IN growth_NN factors_NNS in_IN IL-_NNP 1_CD -_: dependent_JJ
        effects_NNS is_VBZ not_RB clear_JJ cut_NN ,_, since_IN IL-_NNP 1_CD can_MD both_DT induce_VB and_CC
        inhibit_VB proliferation_NN of_IN chondrocytes_NNS [_NN 17_CD ]_NN ._. However_RB ,_, in_IN
        the_DT present_JJ model_NN of_IN SW_NNP 1353_CD cells_NNS under_IN serum-free_JJ
        conditions_NNS ,_, we_PRP did_VBD not_RB observe_VB a_DT mitogenic_JJ effect_NN of_IN IL-_NNP 1_CD
        (_( data_NNS not_RB shown_VBN )_) ._.
        Bone_NNP morphogenetic_JJ protein_NN 4_CD (_( BMP_NN 4_LS )_) is_VBZ a_DT member_NN of_IN the_DT
        TGF-β_NNP superfamily_RB of_IN proteins_NNS and_CC is_VBZ required_VBN for_IN
        chondrocyte_NN differentiation_NN and_CC cartilage_NN maintenance_NN [_NN 42_CD ,_,
        43_CD ]_NN ._. The_DT observed_VBN suppression_NN of_IN its_PRP$ expression_NN in_IN
        chondrocytes_NNS by_IN IL-_NNP 1_CD β_NN (_( Table_NNP 2_CD ,_, panel_NN B_NNP )_) is_VBZ consistent_JJ with_IN
        a_DT previous_JJ report_NN in_IN osteoblastic_JJ cells_NNS [_NN 44_CD ]_NN and_CC suggests_VBZ
        that_IN IL-_NNP 1_CD β_NN may_MD enhance_VB cartilage_NN degradation_NN by_IN blocking_VBG an_DT
        essential_JJ autocrine_NN signal_NN for_IN chondrocyte_NN maturation_NN and_CC
        function_NN ._.
        IL-_NNP 1_CD induction_NN of_IN several_JJ MMP_NNP family_NN members_NNS is_VBZ seen_VBN ,_,
        including_VBG collagenase-_NN 3_CD (_( MMP-_NNP 13_CD )_) ,_, matrilysin_NN (_( MMP-_NNP 7_CD )_) ,_, and_CC
        metalloelastase_NN (_( MMP-_NNP 12_CD )_) (_( Table_NNP 2_CD ,_, panel_NN C_NNP )_) ._. The_DT
        collagenase-_NN 1_CD (_( MMP-_NNP 1_LS )_) gene_NN was_VBD not_RB significantly_RB induced_VBN in_IN
        this_DT array_NN ,_, and_CC this_DT is_VBZ consistent_JJ with_IN our_PRP$ previous_JJ
        findings_NNS that_IN MMP-_NNP 1_CD is_VBZ expressed_VBN at_IN lower_JJR levels_NNS than_IN
        MMP-_NNP 13_CD in_IN SW_NNP 1353_CD cells_NNS [_NN 11_CD ]_NN ._. Furthermore_RB ,_, the_DT magnitude_NN of_IN
        increase_NN observed_VBD for_IN these_DT MMP_NNP genes_NNS was_VBD modest_JJ ,_, despite_IN
        the_DT fact_NN that_IN MMP_NNP genes_NNS are_VBP strongly_RB induced_VBN in_IN response_NN to_TO
        IL-_NNP 1_CD β_NN ._. However_RB ,_, the_DT most_RBS likely_JJ explanation_NN for_IN the_DT low_JJ
        level_NN of_IN induction_NN seen_VBN here_RB is_VBZ the_DT fact_NN that_IN MMPs_NNP are_VBP not_RB
        '_POS early_JJ response_NN genes_NNS '_'' ._. Rather_RB ,_, they_PRP are_VBP the_DT downstream_JJ
        targets_NNS of_IN the_DT signal_NN /_NN transduction_NN pathways_NNS and_CC
        transcription_NN factors_NNS that_WDT do_VBP represent_VB early_JJ responses_NNS ._.
        Indeed_RB ,_, RT-PCR_NNP confirmed_VBD that_IN MMP-_NNP 13_CD mRNA_NN continues_VBZ to_TO
        increase_VB 4_CD hours_NNS after_IN IL-_NNP 1_CD treatment_NN (_( Fig_NNP ._. 1_LS )_) ._. This_DT is_VBZ
        consistent_JJ with_IN our_PRP$ previously_RB published_VBN finding_VBG that_IN
        steady-state_JJ MMP-_NNP 13_CD mRNA_NN levels_NNS peak_NN 12_CD hours_NNS after_IN IL-_NNP 1_CD
        treatment_NN of_IN chondrocytes_NNS [_NN 11_CD ]_NN ._.
        Tenascin_NNP ,_, an_DT adhesion_NN molecule_NN that_WDT is_VBZ expressed_VBN during_IN
        cartilage_NN development_NN [_NN 45_CD ]_NN ,_, was_VBD induced_VBN by_IN IL-_NNP 1_CD β_NN in_IN SW_NNP 1353_CD
        cells_NNS (_( Table_NNP 2_CD ,_, panel_NN C_NNP )_) ._. Interestingly_RB ,_, the_DT tenascin_NN gene_NN
        has_VBZ been_VBN reported_VBN to_TO be_VB IL-_NNP 1_CD -_: inducible_JJ in_IN synovial_NN cells_NNS
        and_CC chondrocytes_NNS ,_, and_CC its_PRP$ expression_NN is_VBZ enhanced_VBN in_IN
        rheumatoid_NN arthritis_NN and_CC OA_NNP [_NN 46_CD ,_, 47_CD ]_NN ._. A_DT possible_JJ
        physiologic_JJ consequence_NN of_IN IL-_NNP 1_CD β-induced_JJ tenascin_NN
        expression_NN is_VBZ that_IN it_PRP may_MD promote_VB chondrocyte_NN migration_NN
        towards_IN the_DT sites_NNS of_IN lesions_NNS in_IN OA_NNP [_NN 47_CD ]_NN ._. IL-_NNP 1_CD β_NN
        coordinately_RB reduced_VBD expression_NN of_IN integrin_NN a_DT 1_CD ,_, a_DT
        cell-adhesion_JJ molecule_NN that_IN chondrocytes_NNS use_VBP to_TO bind_NN to_TO
        type_NN II_NNP collagen_NN [_NN 48_CD ]_NN ._. Thus_RB ,_, IL-_NNP 1_CD β_NN treatment_NN may_MD modify_VB
        adhesion_NN molecule_NN expression_NN ,_, so_IN that_DT matrix_NN adhesion_NN is_VBZ
        compromised_VBN ._.
        We_PRP found_VBD that_IN IL-_NNP 1_CD β_NN changed_VBD the_DT expression_NN levels_NNS for_IN
        several_JJ signaling_VBG proteins_NNS and_CC tumor_NN suppressor_NN genes_NNS
        (_( Table_NNP 2_CD ,_, panel_NN D_NNP )_) ,_, but_CC the_DT significance_NN of_IN these_DT changes_NNS
        is_VBZ not_RB clear_JJ ._. Proteins_NNPS associated_VBN with_IN G-_NNP protein_NN signaling_VBG
        were_VBD both_DT increased_VBN (_( rho_NN 6_CD ,_, Gem_NNP ,_, and_CC regulator_NN of_IN G_NNP protein_NN
        signaling_VBG )_) and_CC decreased_VBD (_( rho_NN 7_CD ,_, RAD_NNP 1_CD ,_, and_CC p_NN 160_CD ROCK_NNP )_) ._.
        Jagged_NNP ,_, which_WDT is_VBZ a_DT transmembrane_NN ligand_NN for_IN the_DT Notch_NNP
        signaling_VBG pathway_NN [_NN 49_CD ]_NN ,_, is_VBZ induced_VBN by_IN IL-_NNP 1_CD β_NN ._.
        Interestingly_RB ,_, jagged-_NN 1_CD is_VBZ important_JJ for_IN
        epithelial-mesenchymal_JJ cell_NN interaction_NN in_IN development_NN [_NN
        50_CD ]_NN ,_, and_CC mutations_NNS in_IN the_DT jagged_JJ gene_NN lead_NN to_TO Alagille_NNP
        syndrome_NN ,_, a_DT congenital_NN connective_JJ tissue_NN disorder_NN whose_WP$
        hallmarks_NNS include_VBP craniofacial_NN and_CC vertebral_NN deformities_NNS [_NN
        51_CD ]_NN ._. Zhao_NNP and_CC colleagues_NNS [_NN 52_CD ]_NN identified_VBD frizzled_JJ (_( denoted_JJ
        FZD_NNP 2_LS )_) as_IN the_DT human_JJ homologue_NN of_IN the_DT 
        Drosophila_NNP polarity-determining_JJ gene_NN ._.
        Of_IN potential_JJ importance_NN is_VBZ the_DT fact_NN that_IN frizzled_JJ family_NN
        members_NNS have_VBP recently_RB been_VBN implicated_VBN by_IN Carson_NNP and_CC
        colleagues_NNS in_IN rheumatoid_NN arthritis_NN [_NN 53_CD ]_NN ._. A_DT new_JJ frizzled_JJ
        family_NN member_NN that_WDT is_VBZ expressed_VBN in_IN chondrocytes_NNS and_CC is_VBZ
        involved_VBN in_IN skeletal_NN morphogenesis_NNS has_VBZ been_VBN described_VBN [_NN
        54_CD ]_NN ._. Perhaps_RB down-regulation_JJ of_IN frizzled_JJ family_NN members_NNS by_IN
        IL-_NNP 1_CD β_NN is_VBZ deleterious_JJ to_TO chondrocyte_NN function_NN and_CC can_MD
        contribute_VB to_TO OA_NNP ._.
      
      
        Conclusions_NNP
        Along_IN with_IN confirming_VBG changes_NNS in_IN gene_NN expression_NN already_RB
        known_VBN to_TO be_VB associated_VBN with_IN IL-_NNP 1_CD β_NN stimulation_NN ,_, chondrocyte_NN
        biology_NN ,_, and_CC MMP_NNP gene_NN regulation_NN ,_, this_DT microarray_NN
        identified_VBD several_JJ other_JJ induced_VBN and_CC repressed_JJ genes_NNS whose_WP$
        roles_NNS in_IN chondrocyte_NN biology_NN are_VBP yet_RB to_TO be_VB defined_VBN ._. While_IN
        the_DT significance_NN of_IN these_DT findings_NNS in_IN terms_NNS of_IN
        understanding_NN IL-_NNP 1_CD effects_NNS on_IN chondrocytes_NNS is_VBZ still_RB
        uncertain_JJ ,_, the_DT documentation_NN of_IN these_DT changes_NNS in_IN gene_NN
        expression_NN may_MD provide_VB the_DT basis_NN for_IN future_JJ studies_NNS on_IN the_DT
        molecular_JJ effects_NNS of_IN IL-_NNP 1_CD on_IN chondrocytes_NNS and_CC on_IN other_JJ cell_NN
        types_NNS as_RB well_RB ._.
      
      
        Abbreviations_NNP
        AP-_NNP 1_CD =_SYM activator_NN protein-_NN 1_CD ;_: COL_NNP 2_CD A_DT 1_CD =_SYM procollagen_NN 2_CD alpha_NN
        1_CD ;_: egr-_NN 1_CD =_SYM early_JJ growth_NN response_NN gene-_NN 1_CD ;_: ets_NNS =_SYM
        erythroblastosis_NNS gene_NN twenty-six_JJ ;_: IL-_NNP 1_CD β_NN =_SYM interleukin-_NN 1_CD β_NN ;_:
        LH_NNP =_SYM lactalbumin_NN hydrolysate_NN ;_: LIF_NNP =_SYM leukemia_NN inhibitory_NN
        factor_NN ;_: MAPK_NNP =_SYM mitogen-activated_JJ protein_NN kinase_NN ;_: MMP_NNP =_SYM
        matrix_NN metalloproteinase_NN ;_: NF-κB_NNP =_SYM nuclear_JJ factor-κ_JJ B_NNP ;_: OA_NNP =_SYM
        osteoarthritis_NNS ;_: PDGF_NNP =_SYM platelet-derived_JJ growth_NN factor_NN ;_:
        RT-PCR_NNP =_SYM reverse_VB transcriptase_NN polymerase_NN chain_NN reaction_NN ;_:
        SMAD_NNP 4_CD =_SYM mothers_NNS against_IN dpp_NN homolog_NN 4_CD ;_: TGF-β_NNP =_SYM transforming_VBG
        growth_NN factor-β_JJ ._.
      
    
  
